Sergio Cerdas

Company: Novartis AG

Job title: Global Head of Radioligand Therapies & Technical Operations

Seminars:

Panel Discussion: Designing for Demand – Process Strategies to Support Scale-Up of Radiotherapeutic Manufacturing 1:30 pm

Evaluating scale-up vs. scale-out approaches in radiopharmaceutical manufacturing. Efficiencies for making the transition from Phase 3 to commercial. Future-proofing production by aligning process design with commercial demand forecast. Planning processes that accommodate isotope variability, decay kinetics, and short half-lives.Read more

day: Conference Day Two